NASDAQ$NRC

NRC Health · Q2 2014 earnings

Q2 2014 earnings · · Investor relations

Headline financials

Total Revenue

$24M

Previous: $22.4M+7.4%
EPS (adj)

$0.16

Previous: $0.14+17.9%
Net Income

$4.05M

Previous: $3.43M+18.0%
Operating Income

$6.32M

Previous: $5.53M+14.2%
Gross Profit

$13.2M

Previous: $12.9M+2.9%
R&D Expense

$0.00

Previous: $0.00

Revenue & EPS history

NRC · Revenue · Quarterly

$24M

Q2 2014+7.4%vs Q2 2013

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

-0.9%

Avg return

Earnings day

-0.9%

Avg return

5 days after

-0.3%

Avg return

30 days after

54%

28 / 52 earnings

Positive

+16.1%

Q3 2025

Best reaction

-19.9%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026———
Q1 2026-0.6%+7.9%+16.0%
Q4 2025-19.9%-27.2%-35.9%
Q3 2025+16.1%+17.0%+51.2%
Q2 2025+2.1%+4.8%+6.7%
Q1 2025+7.0%+7.6%+20.2%
Q4 2024-11.9%-11.0%-22.6%
Q3 2024+2.6%-2.1%+4.5%
Q2 2024-11.7%-9.3%-7.2%
Q1 2024-15.3%-11.6%-23.7%
Q4 2023+2.2%+0.6%+1.7%
Q3 2023-1.9%-0.3%-1.1%
Q2 2023+2.2%-0.4%-2.6%
Q1 2023-8.3%-5.2%-1.2%
Q4 2022+4.8%+5.3%-1.8%
Q3 2022-13.5%-8.3%-3.5%
Q2 2022-4.1%-7.4%-12.8%
Q1 2022-5.3%-3.6%+5.0%
Q4 2021-1.5%-4.5%-4.7%
Q3 2021+6.7%+6.7%-8.1%
Q2 2021-0.8%-0.2%+1.6%
Q1 2021-10.2%-5.1%-7.0%
Q4 2020-0.7%-3.9%+0.3%
Q3 2020+1.8%-0.1%-7.8%
Q2 2020-4.1%-1.0%-3.0%
Q1 2020+4.6%+10.3%+12.7%
Q4 2019+0.3%+1.8%-36.0%
Q3 2019-0.4%+0.2%+7.5%
Q2 2019+3.0%+2.6%+1.0%
Q1 2019+7.1%+13.1%+26.5%
Q4 2018+0.6%+2.7%+0.2%
Q3 2018+3.5%+2.4%+4.8%
Q2 2018-0.3%-0.3%+2.4%
Q1 2018+7.3%+5.5%+5.4%
Q4 2017-7.4%-7.9%-9.7%
Q3 2017-10.1%-11.5%-7.7%
Q2 2017+0.9%+1.7%+9.9%
Q1 2017+0.8%-3.4%-3.0%
Q4 2016-3.0%-4.9%+0.5%
Q3 2016-4.6%-1.0%+5.2%
Q2 2016+0.3%+2.3%+2.2%
Q1 2016+2.0%——
Q4 2015+0.6%——
Q3 2015+1.5%——
Q2 2015-2.4%——
Q1 2015+1.3%——
Q4 2014-0.8%——
Q3 2014+0.9%——
Q2 2014+3.8%——
Q1 2014+3.9%——
Q4 2013+5.1%——
Q3 2013+1.0%——
Q2 2013-1.2%——
Q1 2013———
Q4 2012———
Q2 2010———
Q3 2012———
Q2 2012———
Q1 2012———
Q4 2011———
Q1 2011———
Q3 2011———
Q3 2010———
Q4 2009———
Q2 2011———
Q4 2010———
Q1 2010———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro